MedPath

Feasibility of a Smart-phone Based Support System for Hazardous Drinkers

Not Applicable
Completed
Conditions
Alcohol Consumption
Registration Number
NCT03553056
Lead Sponsor
University of Auckland, New Zealand
Brief Summary

A feasibility trial to determine whether six months access to the New Zealand 'Step Away' app can reduce the frequency of alcohol abuse and increase engagement with substance abuse-related health services by hazardous drinkers

Detailed Description

Rationale: Hazardous drinking is an established drinking pattern that carries a risk of harming the drinker's physical and psychological health, and/or having a harmful social effect on the drinker, their families and the community. Interventions to support people who are drinking at hazardous levels are proven to be beneficial and cost-effective at both individual and population levels. However, very few people report having received help to reduce their alcohol consumption, despite support being available. Those who do seek help predominantly talk to their GP first, who then refers them for specialist support. Consequently, there remains a significant gap between the population 'in need' of treatment and those actually engaged in treatment. Mobile-phone based alcohol interventions have the potential to function as a stand-alone intervention to help people address their alcohol problem, and/or act as a conduit to more intensive treatment. 'Step Away' is a smartphone-delivered health intervention designed in the USA to help individuals moderate or abstain completely from drinking alcohol. It is the only alcohol-related mobile app whose development was informed by an empirically-supported intervention grounded in a psychological theory. While the app has shown promise in a North American sample, a well-powered clinical trial of the intervention has yet to be undertaken. In its current form the app is not suitable for adoption in New Zealand as it uses North American drinking norms and safe drinking guidelines, numerous "Americanisms" and the imperial measurement system, and it focuses on US care services. However, a New Zealand version of 'Step Away' could easily be developed, with input from New Zealand stakeholders and end-users.

Aims: To 1) adapt the "Step Away' app for New Zealand, then 2) undertake a feasibility study to determine whether six months access to the app can reduce the frequency of alcohol abuse and increase engagement with substance abuse-related health services in adult, hazardous drinkers in Auckland.

Design: Double-blind, randomised-controlled trial.

Recruitment: Community advertising, including social media.

Sample size: As a feasibility study, no sample size calculation was undertaken. However, 200 people (100 in each arm) will provide sufficient data to ascertain the direction and likely effect size for the various alcohol-related outcomes, the likely recruitment rate, and estimates around participant retention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
114
Inclusion Criteria
  • reside in Auckland, New Zealand
  • at least 18 years of age
  • have access to a smartphone
  • report that they currently drink alcohol
  • have had at least two episodes of binge drinking (defined as six or more drinks on one occasion) in the past 30 days
  • meet the criteria for hazardous drinking (i.e. 8-19 on the AUDIT)
  • express motivation to moderate or abstain from drinking.
Exclusion Criteria
  • Identified during screening as having moderate to severe alcohol dependence (≥20 score on the AUDIT)
  • Currently enrolled in an alcohol programme
  • Another person in the household is already a participant.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of days spent hazardously drinking in the last 30 daysMeasured at 6 months post-randomization
Secondary Outcome Measures
NameTimeMethod
Drinking-related problemsMeasured at 6 months post-randomization

Measured by the Short Inventory of Problems - Revised (SIP-R)

Percentage of days spent hazardously drinking in the last 30 daysMeasured at 1 month post-randomization
App utlizationMeasured at 2 weeks post-randomization
Number of days spent hazardously drinking in the last 30 daysMeasured at 1 month post-randomization
Medical help sought for any moderate-severe alcohol withdrawal signs and symptomsMeasured at 2 weeks post-randomization

Measured as 'Yes' or 'No'

Drinks per day over the last 30 daysMeasured at 1 month post-randomization
Any contact with substance abuse-related health services since randomizationMeasured at 2 weeks post-randomization

Measured as 'Yes' or 'No'

Withdrawal from studyMeasured at 2 weeks post-randomization
Alcohol withdrawalMeasured at 2 weeks post-randomization

Experience of any specific signs and symptoms (i.e. shakiness, sweating, vomiting, fast heart rate, mild fever, seizures, seeing or hearing things that others do not, confusion, shivering, other) since randomization, that may be due to changing the amount of alcohol consumed. Recorded as: not at all, mild, moderate, severe.

Who they have talked to about their drinking, since randomizationMeasured at 2 weeks post-randomization

'Yes' or 'No' answers to options of 'Partner, Family, Whanau, GP/Doctor, Other'

Serious adverse eventsMeasured at 2 weeks post-randomization
Loss to follow-upMeasured at 2 weeks post-randomization
Still experiencing any moderate-severe alcohol withdrawal signs and symptomsMeasured at 2 weeks post-randomization

Measured as 'Yes' or 'No'

Any contact with substance abuse-related health services since randomizationsMeasured at 3 month post-randomization

Measured as 'Yes' or 'No'

Trial Locations

Locations (1)

National Institute for Health Innovation, University of Auckland

🇳🇿

Auckland, New Zealand

National Institute for Health Innovation, University of Auckland
🇳🇿Auckland, New Zealand

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.